Insights

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...

Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.

See a short video explaining how trace amine–associated receptor 1 (TAAR1) affects neurotransmitters in the brain.

In this video, 3 experts discuss the challenge of treating schizophrenia with the current medications, which target blockade of dopaminergic receptors, and explore 4 new medications (ulotaront, KarXT, CVL-231,...

AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the...